Latest Updates

Product is therapeutically equivalent to Jublia; company holds 234 USFDA ANDA approvals

Only two monoclonal antibodies approved in both markets with no small molecules cleared

CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management

Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership

351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA

Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year

Report highlights voltage-gated sodium channel inhibitors, pipeline trends and regulatory incentives in pain treatment

TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeholders during Hyderabad and Bengaluru visit

Company commemorates centenary of founder and recalls his role in building India’s pharma manufacturing base

Vineet Unnikrishnan and Sonu Bhasi, Cyril Amarchand Mangaldas; examine the scope of directors’ liability and vicarious…

Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic therapy

Acquisition strengthens gynaecology portfolio and marks entry into hormone replacement therapy segment

Ayush Pavilion presents digital public health platform and AI tools for traditional medicine

GPQS 2026 to focus on talent, technology and trust in pharma operations

CRO outlines global drug discovery offering across North America and Europe

Transdermal collagen gel serum introduced for regenerative skincare in India

Study outlines integration of AI, discovery science and manufacturing in global and Indian biopharma

Project to deliver over 1 million sq ft of laboratory infrastructure in Hyderabad over six years

Drug-free handheld device introduced at Rs. 990 per unit under agreement with AeroDel Technology Innovations

Partnership expands CNS portfolio through launch of antidepressant developed on Flexitab platform